Search results for "Compromise"

showing 10 items of 220 documents

Association between marfan syndrome and oral health status : a systematic review and meta-analysis

2019

Background: The purpose was to identify and assess the existing scientific evidence from epidemiologic, non-experimental, observational studies of associations between Marfan’s syndrome and oral diseases. Material and Methods: Electronic literature searches in MEDLINE (OVID), The Cochrane Library, Scopus and the Web of Science were conducted to identify all relevant articles. Eligibility was based on inclusion criteria, and quality assessments were conducted. The outcome variables were probing depth, gingival margin, clinical attachment level, bleeding on probing, gingival status, periodontal status, tooth mobility, furcation involvement and decayed, missing and filled teeth index. After ex…

Marfan syndromemedicine.medical_specialtyCàries dentalCross-sectional studyBleeding on probingMEDLINEOral HealthMalalties periodontalsReviewCochrane LibraryMarfan SyndromeTooth mobility03 medical and health sciences0302 clinical medicineOral hygieneInternal medicinemedicineHumansGeneral Dentistrybusiness.industryConnective tissues diseases030206 dentistry:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseMedically compromised patients in DentistryHigiene bucalCross-Sectional StudiesOtorhinolaryngologyMeta-analysisUNESCO::CIENCIAS MÉDICASDental cariesSurgeryMalalties del teixit connectiumedicine.symptomPeriodontal diseasebusinessGingival margin
researchProduct

Non-dominated “trade-off” solutions in television scheduling optimization

2014

The main approaches for the television scheduling design are commonly based on the ratings or revenues maximization objective, and thus, only a single optimal solution can be obtained, corresponding to the best result for the considered objective. Therefore, these approaches lead up to the alternative solutions loss which, even if less effective from the ratings or revenues maximization viewpoint, may be more suitable for the decision maker because of better compromise in relation to factors influencing the decision process. Specifically, such a compromise could be achieved through a suitable “trade-off” between these factors, with reference to the decision context in which the decision mak…

Mathematical optimizationOperations researchRelation (database)Computer scienceStrategy and ManagementCompromisemedia_common.quotation_subjecttelevision scheduling designtelevision scheduling costsScheduling (production processes)integer mathematical programming modelMaximizationManagement Science and Operations ResearchMulti-objective optimizationComputer Science Applicationstelevision ratings forecastmulti-objective optimizationOrder (exchange)Management of Technology and InnovationBusiness and International ManagementSettore ING-IND/16 - Tecnologie E Sistemi Di LavorazioneInteger (computer science)media_commonCommunication channel
researchProduct

Clinical use of polymerase chain reaction performed on peripheral blood and bone marrow samples for the diagnosis and monitoring of visceral leishman…

2007

Background To overcome some of the limitations of conventional microbiologic techniques, polymerase chain reaction (PCR)-based assays are proposed as useful tools for the diagnosis of visceral leishmaniasis. Patients and methods A comparative study using conventional microbiologic techniques (i.e., serologic testing, microscopic examination, and culture) and a Leishmania species-specific PCR assay, using peripheral blood and bone marrow aspirate samples as templates, was conducted during an 8-year period. The study cohort consisted of 594 Italian immunocompetent (adult and pediatric) and immunocompromised (adult) patients experiencing febrile syndromes associated with hematologic alteration…

Microbiology (medical)AdultMalePathologymedicine.medical_specialtyHepatosplenomegalyHIV InfectionsPolymerase Chain ReactionSensitivity and Specificitylaw.inventionSerologyImmunocompromised HostlawBone MarrowBiopsymedicineAnimalsHumansSerologic TestsProspective StudiesChildPolymerase chain reactionAgedLeishmaniamedicine.diagnostic_testAIDS-Related Opportunistic Infectionsbusiness.industryInfantLeishmaniasisMiddle Agedmedicine.diseaseInfectious Diseasesmedicine.anatomical_structureVisceral leishmaniasisPCRItalyChild PreschoolImmunologyLeishmaniasis VisceralFemaleBone marrowViral diseasemedicine.symptombusinessAlgorithms
researchProduct

Forty-one recent cases of invasive zygomycosis from a global clinical registry.

2009

Background Invasive zygomycosis accounts for a significant proportion of all invasive fungal diseases (IFD), but clinical data on the clinical course and treatment response are limited. Patients and methods Fungiscope-A Global Rare Fungal Infection Registry is an international university-based case registry that collects data of patients with rare IFD, using a web-based electronic case form at www.fungiscope.net. Results Forty-one patients with invasive zygomycosis from central Europe and Asia were registered. The most common underlying conditions were malignancies (n = 26; 63.4%), diabetes mellitus (n = 7; 17.1%) and solid organ transplantation (n = 4; 9.8%). Diagnosis was made by culture …

Microbiology (medical)AdultMalemedicine.medical_specialtyPosaconazoleAntifungal AgentsAsiaAdolescentDatabases FactualItraconazoleDiabetes ComplicationsImmunocompromised HostYoung AdultZygomycosisAmphotericin BInternal medicineAmphotericin BNeoplasmsmedicineHumansPharmacology (medical)ChildSurvival analysisMycosisAgedPharmacologyAged 80 and overbusiness.industryMucormycosisOrgan TransplantationMiddle Agedmedicine.diseaseSurvival AnalysisSurgeryEuropeInfectious DiseasesTreatment OutcomeChild PreschoolChemoprophylaxisMucoralesFemaleZygomycosisbusinessmedicine.drugThe Journal of antimicrobial chemotherapy
researchProduct

Antifungal prophylaxis for invasive mycoses in high risk patients.

2006

New broader spectrum antifungal agents with favorable safety profiles have been available for the last 15 years making prophylaxis feasible. The purpose of this article is to review recent studies in patient populations at high risk for invasive fungal infections.Itraconazole, lipid formulations of amphotericin B, posaconazole, caspofungin and micafungin have been utilized for prophylaxis in different immunocompromised host settings. Itraconazole and caspofungin remain an option especially in patients with hematological diseases. Low dose liposomal amphotericin B shows a lower morbidity rate in patients treated for acute myeloid leukemia. Posaconazole demonstrated survival benefits in this …

Microbiology (medical)Antifungalmedicine.medical_specialtyClinical Trials as TopicHigh risk patientsAntifungal Agentsbusiness.industrymedicine.drug_classImmunocompromised HostInfectious DiseasesInvasive MycosesMycosesMedicineHumansIn patientbusinessIntensive care medicineCurrent opinion in infectious diseases
researchProduct

Sepsis due to Erysipelothrix rhusiopathiae in a Patient with Chronic Lymphocytic Leukemia Associated with Bronchopneumonia due to PSeudomonas aerugin…

2015

Erysipelothrix rhusiopathiae infections can typically be attributed to exposure to animal products; thus, these infections are more common among farmers, butchers and veterinarians, among others. This article describes a case involving a 54-year-old man who had relative neutropenia subsequent to treatment for chronic lymphocytic leukemia. The patient developed E rhusiopathiae bacteremia with concomitant pneumonia. The author of this article suggests a likely route of infection, which is atypical considering the patient did not report exposure to animal products.

Microbiology (medical)Chronic lymphocytic leukemiaCase ReportBronchopneumoniaANIMAL EXPOSUREInfectious and parasitic diseasesRC109-216Erysipelothrix rhusiopathiaemedicine.disease_causeMicrobiologyMicrobiologySepsisSepsisMedicineEscherichia coliImmunocompromised hostbiologyErysipelothrix rhusiopathiaebusiness.industryPseudomonas aeruginosabiology.organism_classificationmedicine.diseaseQR1-502Infectious DiseasesConcomitantImmunologybusinessCanadian Journal of Infectious Diseases and Medical Microbiology
researchProduct

New methods of delivery of amphotericin B.

1993

Fungal infections continue to be a major problem in the management of immunocompromised patients. Despite its formidable toxicity and treatment failures, amphotericin B is still the drug of choice for most of these infections. One strategy for reducing the toxicity of amphotericin B and thus permitting administration of higher doses is that of using less toxic formulations. Entrapping amphotericin B into liposomes or binding it to other substances reduces its toxicity to host cells, whereas the selective binding of amphotericin B to ergosterol preserves its toxicity to fungal cells. Adding fungus-specific antibodies to such liposomes may further increase the efficiency of drug targeting. Th…

Microbiology (medical)DrugTime Factorsmedia_common.quotation_subjectPharmacologyAspergillosisRoute of administrationImmunocompromised HostAmphotericin BAmphotericin BMedicineAnimalsAspergillosisHumansAdministration Intranasalmedia_commonAerosolsDosage Formsbusiness.industrymedicine.diseaseClinical trialInfectious DiseasesTargeted drug deliveryMycosesToxicityNasal administrationbusinessmedicine.drugClinical infectious diseases : an official publication of the Infectious Diseases Society of America
researchProduct

Molecular Diagnosis of Toxoplasmosis in Immunocompromised Patients: a 3-Year Multicenter Retrospective Study

2015

ABSTRACT Toxoplasmosis is a life-threatening infection in immunocompromised patients (ICPs). The definitive diagnosis relies on parasite DNA detection, but little is known about the incidence and burden of disease in HIV-negative patients. A 3-year retrospective study was conducted in 15 reference laboratories from the network of the French National Reference Center for Toxoplasmosis, in order to record the frequency of Toxoplasma gondii DNA detection in ICPs and to review the molecular methods used for diagnosis and the prevention measures implemented in transplant patients. During the study period, of 31,640 PCRs performed on samples from ICPs, 610 were positive (323 patients). Blood ( n …

Microbiology (medical)Microbiological Techniquesmedicine.medical_specialtyMESH: Molecular Diagnostic TechniquesAsymptomaticPolymerase Chain Reactionlaw.inventionImmunocompromised Host[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseaseslawInternal medicinemedicineMESH: Immunocompromised HostPrevalenceHumansComputingMilieux_MISCELLANEOUSPolymerase chain reactionImmunodeficiencySurvival analysisMESH: PrevalenceRetrospective Studies[SDV.EE.SANT]Life Sciences [q-bio]/Ecology environment/HealthMESH: Humansbusiness.industryIncidence (epidemiology)MESH: ToxoplasmaMESH: Microbiological TechniquesRetrospective cohort studyMESH: Polymerase Chain ReactionMESH: Retrospective Studiesmedicine.diseaseSurvival AnalysisToxoplasmosis3. Good healthSurgeryMESH: France[SDV.MP]Life Sciences [q-bio]/Microbiology and ParasitologyMolecular Diagnostic TechniquesMESH: Survival AnalysisChemoprophylaxisMESH: ToxoplasmosisParasitologyFrancemedicine.symptombusinessToxoplasmaToxoplasmosis
researchProduct

Visceral leishmaniasis: host-parasite interactions and clinical presentation in the immunocompetent and in the immunocompromised host.

2013

SummaryVisceral leishmaniases are vector-borne parasitic diseases caused by protozoa belonging to the genus Leishmania. The heterogeneity of clinical manifestations and epidemiological characteristics of the disease reflect the complex interplay between the infecting Leishmania species and the genetic and immunologic characteristics of the infected host. The clinical presentation of visceral leishmaniasis depends strictly on the immunocompetency of the host and ranges from asymptomatic to severe forms. Conditions of depression of the immune system, such as HIV infection or immunosuppressive treatments, impair the capability of the immune response to resolve the infection and allow reactivat…

Microbiology (medical)Settore MED/07 - Microbiologia E Microbiologia ClinicaLeishmaniasiSettore MED/17 - Malattie InfettiveDiseaseDisease VectorsHost-Parasite InteractionsImmunocompromised HostImmune systemparasitic diseasesmedicineAnimalsHumansLeishmaniasisTransplantationbiologyHost (biology)Asymptomatic infectionHIVLeishmaniasisGeneral Medicinemedicine.diseasebiology.organism_classificationVirologyTransplantationLeishmaniasis; Vector; Transplantation; HIV; Asymptomatic infection; Immunocompetent host; Immunocompromised hostInfectious DiseasesVisceral leishmaniasisVector (epidemiology)ImmunologyProtozoaLeishmaniasis VisceralVectorImmunocompetent hostLeishmania donovaniInternational journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
researchProduct

Clinical significance of Pneumocystis jirovecii DNA detection by real-time PCR in hematological patient respiratory specimens

2020

Microbiology (medical)Simplexvirusfood.ingredientbusiness.industryPneumonia PneumocystisDNAPneumocystis cariniiReal-Time Polymerase Chain Reactionmedicine.diseaseVirologyImmunocompromised Hostchemistry.chemical_compoundPneumoniaInfectious DiseasesfoodReal-time polymerase chain reactionchemistryPneumocystis jirovecii DNAHumansSimplexvirusMedicineClinical significanceRespiratory systembusinessDNAJournal of Infection
researchProduct